Skip to main content
XNCR
NASDAQ Life Sciences

Xencor Seeks Shareholder Approval for 4 Million Share Increase in Equity Incentive Plan

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
8
Price
$13.1
Mkt Cap
$960.736M
52W Low
$6.92
52W High
$18.69
Market data snapshot near publication time

summarizeSummary

Xencor Inc. filed definitive additional proxy materials for its annual meeting, seeking shareholder approval to increase the shares reserved under its equity incentive plan by 4 million, representing potential future dilution.


check_boxKey Events

  • Proposed Equity Incentive Plan Expansion

    Xencor is seeking shareholder approval to increase the number of shares reserved for issuance under its 2023 Equity Incentive Plan by 4,000,000 shares. At the current stock price, this represents a potential future dilution of approximately $52.4 million.

  • Annual Meeting Proposals

    The filing outlines proposals for the Annual Meeting on June 16, 2026, including the election of nine directors, ratification of KPMG LLP as auditors, and an advisory vote on executive compensation.


auto_awesomeAnalysis

Xencor Inc. has filed definitive additional proxy materials for its upcoming Annual Meeting, highlighting a significant proposal to increase the shares reserved under its 2023 Equity Incentive Plan by 4,000,000 shares. This proposed increase represents a potential future dilution of approximately $52.4 million based on the current stock price. While equity incentive plans are standard for employee retention and motivation, the magnitude of this increase is substantial and could weigh on future share value. This filing also includes routine proposals such as the election of directors and the ratification of auditors. The potential dilution comes amidst recent insider selling activity, which has seen net sales of over $521,000 in the last 90 days.

At the time of this filing, XNCR was trading at $13.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $960.7M. The 52-week trading range was $6.92 to $18.69. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed XNCR - Latest Insights

XNCR
Apr 27, 2026, 4:03 PM EDT
Filing Type: DEFA14A
Importance Score:
8
XNCR
Apr 27, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
7
XNCR
Apr 27, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
XNCR
Mar 09, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
XNCR
Mar 04, 2026, 4:03 PM EST
Source: Wiseek News
Importance Score:
8
XNCR
Mar 04, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
8
XNCR
Feb 25, 2026, 4:02 PM EST
Filing Type: 10-K
Importance Score:
8
XNCR
Feb 25, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
8
XNCR
Jan 08, 2026, 8:05 AM EST
Filing Type: 8-K
Importance Score:
7